The transition from NeeS to eCTD

Introduction & overview

The regulatory landscape, including pharma regulatory affairs, has faced major revolution and transformation by adopting the eCTD format across the globe. Electronic submissions are driving efficient product authorizations and approvals for pharmaceutical organizations to stay ahead of the market. Undoubtedly, these benefits of eCTD are enormous- particularly the fact that the eCTD format reduces the time and resources needed for regulatory submissions. Furthermore, it provides enhance management and tracking of the necessary regulatory information while maintaining compliance. But the transition from paper-based submissions to NeeS to eCTD is not as straightforward as it seems as it is associated with many challenges regarding added cost, resources, and time. 

Transition to the eCTD

One of the main challenges that regulatory professionals face when transitioning to the eCTD is the time and resource it takes. For example, organizations would need to invest in software, staff, and additionally resources. Training and education on the new format will also be needed.

Some regulatory solutions to ensure a successful transition include understanding and including all key stakeholders in the process. This could be regulatory affairs and IT teams among other departments. Companies should also make sure they invest in the training and education of employees which can vary from in-house to online training sessions.

Pharmaceutical organizations that incorporate software and IT systems to support this transition are 2 steps ahead in the game. Many software provide solutions to companies for them to manage their eCTD submissions in a more efficient manner while ensure they maintain compliance. This can include automation of submission and publishing tasks which significantly reduces time, errors, and any discrepancies.  

Partnering with eCTD vendors and industry expertise

One on hand, pharma organizations are encouraged to build, develop, and upgrade their regulatory submission functions. Another option, and a more cost-effective & resource-alleviating one, is to outsource submissions to regulatory consulting organizations and regulatory service providers that have decades of experience and the technological platform to manage submission on behalf of pharma organizations. Indeed, this means that these organizations can spend more time on other operations and tasks that would bring greater business-added-value and ROI.

Regulatory service providers and consulting teams that leverage their smart-tech platforms with their subject matter expertise and regulatory intelligence are at the forefront of the pharma industry. Not only are they aware of some of the industry knowledge and updates, but they are also equipped to handle any obstacles that may emerge. 

Conclusion

Indeed, efficient regulatory submissions in the eCTD format improve the communication between regulatory agencies and pharma organizations such as MAHs and sponsors by creating a standard and harmonized format. Partnering with the right strategic industry expert can help pharma organizations remain ahead of the regulatory landscape and competition by ensure faster, accurate, and more efficient product approval. 


Comments

Post a Comment

Popular posts from this blog

The Role of Artificial Intelligence in Medical Writing and its Effects on Regulatory Compliance

Image
  Introduction: AI has opened new opportunities for researchers and professionals to process, analyze, and interpret data more quickly, creating novel treatments and drug development and creating a huge potential impact on the healthcare and pharmaceutical industries. What does AI mean for the pharmaceutical industry? Developing pharmaceutical drugs through clinical trials can usually take more than a decade. AI can generate that data incredibly quickly, facilitating the creation of new advanced drugs with greater efficiency. Benefits of AI Enhanced productivity Improved customer service Lowering operational costs Improved healthcare research and treatments AI in medical writing Artificial intelligence utilizes machine learning, which needs specific inputs to function and compose results. These inputs come from data sets and algorithms, which enable machines to be trained to identify patterns and relationships between data. In the medical writing field, AI can be used to streamline...
Read more

Risk Management in Regulatory Affairs: Mitigating Compliance Risks

Image
Pharmaceutical companies face significant challenges in navigating a stringent and constantly evolving regulatory environment, coupled with technological advancements and global economic considerations. Assessing and managing risks is vital throughout the entire life cycle of a pharmaceutical product, from research and clinical testing to manufacturing and distribution. Organizations must demonstrate to regulatory authorities that they have a well-documented plan to identify, measure, control, and monitor the various risks. The pharmaceutical industry is highly regulated for good reason, given the critical importance of safety, efficacy, and the impact that medicines and treatments can have on patient’s lives. Regulatory scrutiny spans various aspects of pharmaceutical operations, including sales and marketing, drug price reporting, patient privacy, clinical trials and procedures, preclinical work and testing, and manufacturing. Consequently, ensuring compliance with regulatory affairs...
Read more

Regulatory Compliance and Technology

Image
Regulatory compliance essentially means making sure that all processes and activities are in accordance with, relevant legislations, guidelines, laws, and standards. This is important in regulatory affairs to make sure that all processes involved in pharmaceutical development- from pre to post market stages- are adhere to requirements and standards that would ensure safety, efficacy, & quality and minimize patient risk. Regulatory compliance is priority for all pharma regulatory affairs organizations and in-house departments as non-compliance can not only lead to patient harm but also product recall and subsequent business loss. A business that can meet the standards and requirements that are set by regulatory authorities is also an aspect of regulatory compliance that is important, where certain operations, activities and even the organization’s employees are “in compliance” or not. It is also possible that an organization can be compliant with one set of regulations i.e., for ...
Read more